Sector revisions Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 02:50:30 13/06/2026 HKT			5-day change	1st Jan Change
188.02 ^USD	-0.02%		+3.97%	-5.49%

06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			15
LONZA GROUP AG			23
REVOLUTION MEDICINES, INC.			21
IQVIA HOLDINGS INC.			19
BEONE MEDICINES AG			27
CELLTRION, INC.			24
MEDPACE HOLDINGS, INC.			12
EUROFINS SCIENTIFIC SE			14
ASCENDIS PHARMA A/S	-	-	17
IONIS PHARMACEUTICALS, INC.			25
ICON PUBLIC LIMITED COMPANY			16
TEMPUS AI, INC.			15
BIO-TECHNE CORPORATION			13
ABIVAX			7
QIAGEN N.V.			14
ALKERMES PLC			16
PROTAGONIST THERAPEUTICS, INC.			13
PRAXIS PRECISION MEDICINES, INC.			17
KYMERA THERAPEUTICS, INC.			21
Average			17
Weighted average by Cap.			19